ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed

Investors who lost money in ADMA after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.